CRISPR Therapeutics AG
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has CRISPR Therapeutics AG's balance sheet done over the years? Its assets were worth $2,229,571,000 last year, which is less than in the previous period. 16% of CRISPR Therapeutics AG’s total assets is currently financed by debt. Its liabilities reached the amount of $346,768,000, which means an decrease by -6% compared compared to last year.
Debt to Assets
| 2014 | 1527000 | 8.50M | 556.71% |
|---|---|---|---|
| 2015 | 159423000 | 188.54M | 118.27% |
| 2016 | 344962000 | 112.11M | 32.5% |
| 2017 | 271346000 | 83.51M | 30.78% |
| 2018 | 489016000 | 96.82M | 19.8% |
| 2019 | 1066752000 | 127.32M | 11.94% |
| 2020 | 1827966000 | 163.73M | 8.96% |
| 2021 | 2751877000 | 352.41M | 12.81% |
| 2022 | 2243057000 | 367.57M | 16.39% |
| 2023 | 2229571000 | 346.76M | 15.55% |
CRSP Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 389.47M | 211.88M | 923.03M | 1.16B | 943.77M | 456.64M | 239.75M | 315.52M | 155.96M | 945K |
Short term investments | 1.30B | 1.60B | 1.45B | 521.71M | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 200M | 11.2M | 305K | 144K | 99K | 88K | 2.62M | 3.15M | 339K | 0 |
Inventory | 0 | -11.2M | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
Other current assets | 14.38M | 37.70M | 38.07M | 26.14M | 43.67M | 9.65M | 12.00M | 1.51M | 540K | 23K |
Total current assets | 1.90B | 1.85B | 2.41B | 1.71B | 987.54M | 466.39M | 248.38M | 320.18M | 156.84M | 968K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 305.93M | 320.55M | 312.03M | 93.02M | 72.83M | 18.5M | 18.85M | 21.02M | 1.32M | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 16K | 71K | 125K | 180K | 235K | 289K | 344K | 399K | 454K | 509K |
Long term investments | 1.97M | 53.13M | 16.91M | 16.84M | 5.04M | 0 | 3.15M | 0 | 700K | 0 |
Other non-current assets | 13.56M | 16.27M | 22.20M | 18.14M | 6.13M | 3.83M | 3.76M | 3.34M | 801K | 50K |
Total non-current assets | 321.49M | 390.03M | 334.36M | 111.34M | 79.20M | 22.62M | 22.96M | 24.77M | 2.58M | 559K |
Total assets | 2.22B | 2.24B | 2.75B | 1.82B | 1.06B | 489.01M | 271.34M | 344.96M | 159.42M | 1.52M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 4.10M | 12.32M | 1.01M | 2.34M | 960K | 57.78M | 56.92M | 77.64M | 0 | 0 |
Short term debt | 31.25M | 15.84M | 12.15M | 11.36M | 8.48M | -35.32M | 0 | -60.27M | 0 | 0 |
Total current liabilities | 108.79M | 121.10M | 119.88M | 94.25M | 57.10M | 27.74M | 14.51M | 21.99M | 10.15M | 2.14M |
| Non-current liabilities: | ||||||||||
Long term debt | 223.00M | 228.17M | 212.87M | 50.06M | 44.05M | 0 | 0 | 0 | -26.18M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 958K | 5.96M | 7.33M | 7.63M | 14.39M | 11.29M | 12.07M | 12.47M | -64.07M | 6.35M |
Total non-current liabilities | 237.97M | 246.47M | 232.53M | 69.47M | 70.22M | 69.07M | 69.00M | 90.11M | 178.39M | 6.35M |
Total liabilities | 346.76M | 367.57M | 352.41M | 163.73M | 127.32M | 96.82M | 83.51M | 112.11M | 188.54M | 8.50M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |